Vietnam · Delayed Price · Currency is VND Sage Therapeutics Statistics
Total Valuation
HNX:MED has a market cap or net worth of VND 301.56 billion. The enterprise value is 307.64 billion.
| Market Cap | 301.56B |
| Enterprise Value | 307.64B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
HNX:MED has 12.41 million shares outstanding. The number of shares has decreased by -5.79% in one year.
| Current Share Class | 12.41M |
| Shares Outstanding | 12.41M |
| Shares Change (YoY) | -5.79% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 37.15% |
| Owned by Institutions (%) | n/a |
| Float | 7.80M |
Valuation Ratios
The trailing PE ratio is 25.98.
| PE Ratio | 25.98 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.50 |
| EV / Sales | 0.85 |
| EV / EBITDA | 12.39 |
| EV / EBIT | 17.94 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.41 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 1.79 |
| Debt / FCF | n/a |
| Interest Coverage | 751.91 |
Financial Efficiency
Return on equity (ROE) is 3.54% and return on invested capital (ROIC) is 2.72%.
| Return on Equity (ROE) | 3.54% |
| Return on Assets (ROA) | 1.93% |
| Return on Invested Capital (ROIC) | 2.72% |
| Return on Capital Employed (ROCE) | 5.35% |
| Revenue Per Employee | 1.10B |
| Profits Per Employee | 35.39M |
| Employee Count | 450 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.91 |
Taxes
In the past 12 months, HNX:MED has paid 3.22 billion in taxes.
| Income Tax | 3.22B |
| Effective Tax Rate | 21.72% |
Stock Price Statistics
The stock price has decreased by -12.59% in the last 52 weeks. The beta is 0.10, so HNX:MED's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -12.59% |
| 50-Day Moving Average | 25,636.00 |
| 200-Day Moving Average | 24,338.00 |
| Relative Strength Index (RSI) | 46.67 |
| Average Volume (20 Days) | 896 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:MED had revenue of VND 360.49 billion and earned 11.61 billion in profits. Earnings per share was 935.19.
| Revenue | 360.49B |
| Gross Profit | 83.97B |
| Operating Income | 17.15B |
| Pretax Income | 14.83B |
| Net Income | 11.61B |
| EBITDA | 24.83B |
| EBIT | 17.15B |
| Earnings Per Share (EPS) | 935.19 |
Balance Sheet
The company has 36.29 billion in cash and 44.43 billion in debt, giving a net cash position of -8.14 billion or -656.15 per share.
| Cash & Cash Equivalents | 36.29B |
| Total Debt | 44.43B |
| Net Cash | -8.14B |
| Net Cash Per Share | -656.15 |
| Equity (Book Value) | 320.70B |
| Book Value Per Share | 25,842.05 |
| Working Capital | 65.71B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 23.29%, with operating and profit margins of 4.76% and 3.22%.
| Gross Margin | 23.29% |
| Operating Margin | 4.76% |
| Pretax Margin | 4.11% |
| Profit Margin | 3.22% |
| EBITDA Margin | 6.89% |
| EBIT Margin | 4.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 900.00, which amounts to a dividend yield of 3.70%.
| Dividend Per Share | 900.00 |
| Dividend Yield | 3.70% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 5.79% |
| Shareholder Yield | 9.49% |
| Earnings Yield | 3.85% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:MED has an Altman Z-Score of 2.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 4 |